Skip to content

Clinical trials

Phase 2 Obesity trials in Sweden

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Obesity Phase: Phase 2 Country / region: Sweden Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20073
20081
20101
20131
20141
20151
20182
20211
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.2
Uppsala University2
Alizyme1
Amgen1
Boehringer Ingelheim1
Empros Pharma AB1
Göteborg University1
Janssen Research & Development, LLC1
MedImmune LLC1
Novo Nordisk A/S1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Obesity15
Diabetes Mellitus, Type 24
Overweight4
Nutrition Disorders3
Body Weight2
Metabolic Diseases2
Nutritional and Metabolic Diseases2
Apnea1
Cholecystolithiasis1
Gallstones1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.